Porphyria is a group of rare disorders caused by a buildup of natural chemicals called porphyrins in the body. These chemicals are normally used to make heme, the part of red blood cells that carries oxygen. When one of the eight enzymes needed to complete heme production is missing or not working properly, porphyrins pile up in the skin, nervous system, or other organs and cause a range of symptoms, from severe abdominal pain to blistering skin.
There are several types of porphyria, but they generally fall into two categories: those that primarily affect the nervous system (acute porphyrias) and those that primarily affect the skin (cutaneous porphyrias). Most are inherited, though one common form can be acquired.
How Heme Production Goes Wrong
Your body builds heme through an eight-step assembly line, with each step handled by a different enzyme. The process starts in the mitochondria of cells, moves into the surrounding fluid for four middle steps, then returns to the mitochondria for the final stages. The raw ingredients are glycine (an amino acid) and a molecule from the energy cycle called succinyl-CoA. Step by step, enzymes shape these building blocks into a ring-shaped molecule, and in the final step, an iron atom is inserted into that ring to create heme.
In each type of porphyria, a specific enzyme in this chain is deficient. That creates a bottleneck. The intermediates that would normally move to the next step instead accumulate. Which intermediate builds up determines what kind of symptoms you get. If the buildup happens early in the chain, before the ring structure forms, the accumulating chemicals (called ALA and PBG) are toxic to nerves. If the buildup happens later, after the ring structure has formed, the resulting porphyrins absorb light energy and release it in a way that generates damaging molecules in the skin, causing blistering and scarring on sun-exposed areas.
Acute Porphyria: Nervous System Attacks
The acute porphyrias include acute intermittent porphyria (AIP), which is the most well-known, along with hereditary coproporphyria, variegate porphyria, and an extremely rare form called ALA dehydratase-deficiency porphyria. These types cause episodes, often called “attacks,” that can last days to weeks.
Severe abdominal pain is the hallmark symptom, occurring in over 80% of patients during an attack. The pain typically comes without the abdominal rigidity that doctors associate with surgical emergencies like appendicitis, which can make diagnosis tricky. Nausea, vomiting, and loss of appetite commonly accompany the pain.
The nervous system effects can be widespread. Peripheral nerves may be affected, causing pain in the back and limbs, muscle weakness, and in serious cases, weakness of the muscles used for breathing. The central nervous system can also be involved, leading to seizures, confusion, blurred vision, or even coma in severe episodes. Cardiovascular symptoms like rapid heart rate, irregular heartbeat, and heavy sweating stem from dysfunction of the autonomic nervous system, the part that controls involuntary body functions.
Although attacks come and go, some people develop chronic symptoms that persist between episodes. The label “acute” refers to the dramatic nature of the attacks, not necessarily to how long the disease lasts overall.
Cutaneous Porphyria: Skin Damage From Light
The cutaneous porphyrias primarily affect the skin. Porphyria cutanea tarda (PCT) is the most common porphyria worldwide and causes fragile skin that blisters easily on sun-exposed areas like the hands, forearms, and face. Some patients also experience persistent itching, which can be a significant quality-of-life issue even though it’s not always highlighted in medical descriptions of the disease.
Erythropoietic protoporphyria (EPP) is another cutaneous form that typically appears in childhood. It causes burning pain in the skin within minutes of sun exposure, sometimes before any visible changes appear. Congenital erythropoietic porphyria (CEP) is the rarest and most severe cutaneous type. Prolonged light exposure can cause such extensive skin damage and scarring that patients lose tissue from fingers, ears, or the nose over time.
Two types, hereditary coproporphyria and variegate porphyria, can cause both acute attacks and skin symptoms, placing them in both categories.
What Triggers an Attack
People can carry the genetic mutation for an acute porphyria and never have symptoms. Attacks are often set off by environmental triggers that increase the body’s demand for heme production. When demand spikes, the deficient enzyme can’t keep up, and toxic intermediates flood the system.
Common triggers include:
- Hormonal changes: Many women experience attacks tied to their menstrual cycle, which is one reason acute porphyria is diagnosed more often in women of reproductive age.
- Alcohol: Heavy drinking is a well-established trigger, particularly for PCT.
- Fasting or restrictive dieting: Going without food increases heme demand in the liver.
- Smoking: Tobacco use can provoke or worsen symptoms.
- Certain medications: A number of prescription drugs are unsafe for people with acute porphyria because they stimulate the heme pathway. Patients typically receive a list of safe and unsafe medications at diagnosis.
- Sunlight: The primary trigger for cutaneous forms.
How Porphyria Is Diagnosed
Diagnosis starts with measuring porphyrins and their precursors (ALA and PBG) in urine, blood, and stool. During an acute attack, urine levels of PBG are typically elevated and can be detected with a simple screening test. If initial results are abnormal, additional testing determines which specific porphyria is present, since each type produces a distinct pattern of accumulated chemicals across the three sample types.
Genetic testing can confirm the diagnosis and identify the exact mutation, which is useful for screening family members who may carry the gene but have never had symptoms. Because attacks are episodic and the symptoms overlap with many common conditions, the average time to diagnosis can stretch for years. Porphyria is often called a “great imitator” in medicine because abdominal pain, nausea, and neurological symptoms can point in many diagnostic directions before anyone thinks to check porphyrin levels.
Treatment for Acute Attacks
Mild acute attacks are sometimes managed with a high-carbohydrate intake, typically given intravenously as a glucose solution. Carbohydrates help suppress the heme production pathway and reduce the buildup of toxic intermediates. If symptoms don’t improve within a day or two, or if the attack is severe from the start, a medication derived from human blood called hemin is given intravenously. Hemin essentially provides the finished product (heme) directly, which tells the body to stop overproducing the intermediates that are causing damage. Treatment courses typically last several days.
For patients who experience frequent, recurrent attacks (generally three or more per year), a newer therapy called givosiran offers a preventive approach. Given as a monthly injection under the skin, it works by silencing the gene for the first enzyme in the heme production chain. By dialing down the entire pathway at its starting point, it reduces the production of the toxic intermediates ALA and PBG before they can accumulate. Clinical trials enrolled patients who had experienced at least two attacks in six months, and the treatment significantly reduced attack frequency.
Managing Cutaneous Porphyria
For cutaneous forms, the cornerstone of management is strict sun avoidance and protective clothing. Regular sunscreens are often insufficient because porphyrins react to visible light wavelengths, not just ultraviolet rays, and most sunscreens don’t block visible light effectively.
PCT has a specific and effective treatment: periodic removal of small amounts of blood (phlebotomy), which reduces iron stores in the liver and gradually lowers porphyrin levels. Most patients see improvement within several months. Low doses of certain antimalarial medications can also help by promoting porphyrin excretion. Avoiding alcohol and other known triggers is essential to preventing relapse.
How Common Is Porphyria
Porphyria is rare overall, though prevalence varies by type and population. The genetic mutation for acute intermittent porphyria is present in roughly 600 to 700 per million people of European descent, but the vast majority of carriers never develop symptoms. PCT is the most common porphyria worldwide, in part because it can be acquired rather than solely inherited, with triggers like alcohol, hepatitis C, and excess iron pushing susceptible individuals into symptomatic disease.
The Vampire Myth
Porphyria is sometimes called the “vampire disease” in popular culture, a connection that traces back to a 1985 newspaper article proposing that symptoms of erythropoietic porphyria, particularly sun sensitivity, skin disfigurement, and receding gums that could make teeth appear fang-like, might explain vampire folklore. The theory makes for a compelling story but doesn’t hold up well. Congenital erythropoietic porphyria is extraordinarily rare, with only about 200 cases diagnosed since 1890. More importantly, folkloric vampires were consistently described as healthy-looking when exhumed, not disfigured. The vampire myth is a cultural phenomenon with social and psychological roots, not a medical one.